Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda

BACKGROUND: In Uganda, artemether-lumefantrine (AL) is first-line therapy and dihydroartemisinin-piperaquine (DP) second-line therapy for the treatment of uncomplicated malaria. This study evaluated the efficacy and safety of AL and DP in the management of uncomplicated falciparum malaria and measur...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebong, Chris, Sserwanga, Asadu, Namuganga, Jane Frances, Kapisi, James, Mpimbaza, Arthur, Gonahasa, Samuel, Asua, Victor, Gudoi, Sam, Kigozi, Ruth, Tibenderana, James, Bwanika, John Bosco, Bosco, Agaba, Rubahika, Denis, Kyabayinze, Daniel, Opigo, Jimmy, Rutazana, Damian, Sebikaari, Gloria, Belay, Kassahun, Niang, Mame, Halsey, Eric S., Moriarty, Leah F., Lucchi, Naomi W., Souza, Samaly S. Svigel, Nsobya, Sam L., Kamya, Moses R., Yeka, Adoke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709966/
https://www.ncbi.nlm.nih.gov/pubmed/34952573
http://dx.doi.org/10.1186/s12936-021-04021-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709966/
https://www.ncbi.nlm.nih.gov/pubmed/34952573
http://dx.doi.org/10.1186/s12936-021-04021-5

Ejemplares similares